• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症的流行病学:批判性综述。

Epidemiology of multiple sclerosis: a critical overview.

作者信息

Sadovnick A D, Ebers G C

机构信息

Multiple Sclerosis Clinic, University Hospital-UBC Site, Vancouver, Canada.

出版信息

Can J Neurol Sci. 1993 Feb;20(1):17-29. doi: 10.1017/s0317167100047351.

DOI:10.1017/s0317167100047351
PMID:8467424
Abstract

The decisive conclusions to be drawn from the available epidemiological data, mostly geography and prevalence, of MS are: (1) a north-south (as well as west-east in the United States) gradient exists independent of genetic/racial factors; (2) major differences in prevalence occur in the absence of latitude differences; (3) individuals from the same ethnic derivation have either similar prevalence rates or very different prevalence rates in widely separated geographical areas and (4) specific resistant isolates are shown to exist regardless of latitude. Existing information leads to the almost inescapable conclusion that the epidemiology of MS cannot be explained by any single known environmental or genetic factor(s) in isolation. A combination of a heterogeneous distribution of both genetic and environmental factors appears to be required to explain the available data on MS.

摘要

从现有的关于多发性硬化症(MS)的流行病学数据(主要是地理分布和患病率)中得出的决定性结论如下:(1)存在南北梯度(在美国为东西梯度),且与遗传/种族因素无关;(2)在不存在纬度差异的情况下,患病率存在重大差异;(3)来自同一族裔的个体在相距甚远的地理区域中,患病率要么相似,要么差异很大;(4)无论纬度如何,都存在特定的抗性隔离群。现有信息几乎不可避免地得出这样的结论:MS的流行病学无法用任何单一已知的环境或遗传因素单独解释。似乎需要遗传和环境因素的异质分布相结合来解释关于MS的现有数据。

相似文献

1
Epidemiology of multiple sclerosis: a critical overview.多发性硬化症的流行病学:批判性综述。
Can J Neurol Sci. 1993 Feb;20(1):17-29. doi: 10.1017/s0317167100047351.
2
The geographic distribution of multiple sclerosis: a review.多发性硬化症的地理分布:综述
Neuroepidemiology. 1993;12(1):1-5. doi: 10.1159/000110293.
3
[Epidemiology of multiple sclerosis: environmental factors versus genetic factors].[多发性硬化症的流行病学:环境因素与遗传因素]
Nihon Rinsho. 2003 Aug;61(8):1300-10.
4
The prevalence of multiple sclerosis in the world: an update.全球多发性硬化症患病率:最新情况
Neurol Sci. 2001 Apr;22(2):117-39. doi: 10.1007/s100720170011.
5
Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results.澳大利亚的多发性硬化症流行病学。附新南威尔士州和南澳大利亚州的调查结果。
Med J Aust. 1994 Feb 7;160(3):117-22.
6
A reassessment of the distribution of multiple sclerosis. Part one.多发性硬化症分布的重新评估。第一部分。
Acta Neurol Scand. 1975 Feb;51(2):110-36. doi: 10.1111/j.1600-0404.1975.tb01364.x.
7
Latitudinal prevalence gradient of multiple sclerosis in Latin America.拉丁美洲多发性硬化症的纬度流行梯度。
Mult Scler. 2011 Sep;17(9):1055-9. doi: 10.1177/1352458511405562. Epub 2011 May 6.
8
High prevalence and no latitude gradient of multiple sclerosis in Norway.挪威多发性硬化症的高患病率及无纬度梯度现象。
Mult Scler. 2014 Nov;20(13):1780-2. doi: 10.1177/1352458514525871. Epub 2014 Mar 6.
9
The epidemiology of multiple sclerosis: a general overview.多发性硬化症的流行病学:概述
Ann Neurol. 1994 Dec;36 Suppl 2:S180-93. doi: 10.1002/ana.410360805.
10
Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis.通过紫外线暴露解释多发性硬化症患病率:一项地理空间分析。
Mult Scler. 2009 Aug;15(8):891-8. doi: 10.1177/1352458509105579.

引用本文的文献

1
Key Outcomes for a Vocational Rehabilitation Intervention for People With Multiple Sclerosis: A Nominal Group Technique Study.针对多发性硬化症患者的职业康复干预关键成果:一项名义小组技术研究
Health Expect. 2025 Apr;28(2):e70265. doi: 10.1111/hex.70265.
2
A qualitative study exploring how vocational rehabilitation for people with multiple sclerosis can be integrated within existing healthcare services in the United Kingdom.一项探索如何将多发性硬化症患者的职业康复纳入英国现有医疗保健服务中的定性研究。
BMC Health Serv Res. 2024 Aug 27;24(1):995. doi: 10.1186/s12913-024-11424-y.
3
Development of a Job Retention Vocational Rehabilitation Intervention for People with Multiple Sclerosis Following the Person-Based Approach.
基于人本主义方法为多发性硬化症患者开发的工作保留职业康复干预措施。
Clin Rehabil. 2024 Jul;38(7):965-978. doi: 10.1177/02692155241235956. Epub 2024 Feb 28.
4
An Overview of the History, Pathophysiology, and Pharmacological Interventions of Multiple Sclerosis.多发性硬化症的历史、病理生理学及药物干预概述
Cureus. 2023 Jan 2;15(1):e33242. doi: 10.7759/cureus.33242. eCollection 2023 Jan.
5
Clinical and Radiologic Disease Activity in Pregnancy and Postpartum in MS.多发性硬化症患者妊娠及产后的临床和放射学疾病活动情况。
Neurol Neuroimmunol Neuroinflamm. 2021 Feb 19;8(2). doi: 10.1212/NXI.0000000000000959. Print 2021 Mar.
6
Early Clinical Features, Time to Secondary Progression, and Disability Milestones in Polish Multiple Sclerosis Patients.波兰多发性硬化症患者的早期临床特征、二次进展时间和残疾里程碑。
Medicina (Kaunas). 2019 May 31;55(6):232. doi: 10.3390/medicina55060232.
7
BG-12 and its potential for the prevention of relapse in multiple sclerosis.BG-12及其在预防多发性硬化症复发方面的潜力。
Degener Neurol Neuromuscul Dis. 2012 Sep 28;2:119-132. doi: 10.2147/DNND.S35790. eCollection 2012.
8
Biomedical Variables and Adaptation to Disease and Health-Related Quality of Life in Polish Patients with MS.波兰多发性硬化症患者的生物医学变量与疾病和健康相关生活质量的适应性。
Int J Environ Res Public Health. 2018 Nov 28;15(12):2678. doi: 10.3390/ijerph15122678.
9
BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders.脑源性神经营养因子多态性:关于其在神经退行性疾病中的诊断及临床相关性的综述
Aging Dis. 2018 Jun 1;9(3):523-536. doi: 10.14336/AD.2017.0717. eCollection 2018 Jun.
10
Somatic Symptoms of Depression and Anxiety in People with Multiple Sclerosis.多发性硬化症患者抑郁和焦虑的躯体症状
Int J MS Care. 2018 May-Jun;20(3):145-152. doi: 10.7224/1537-2073.2017-069.